Evidence map›Paper›PMID 37814253›Full record

ArticleBMC pulmonary medicine2023

Bronchodilator reversibility testing in morbidly obese non-smokers: fluticasone/salmeterol efficacy versus salbutamol bronchodilator.

Mona Ibrahim Ahmed, Randa Ibrahim Ahmed, Hasnaa Osama, Amira Karam Khalifa, Abdullah Ali Alshehri, Gaber El-Saber Batiha, Walaa A Negm, Marwa Kamal

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC pulmonary medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 2 countries.

Mona Ibrahim AhmedDepartment of chest Ds & TB, Faculty of Medicine, Fayoum University, Fayoum, Egypt.
Randa Ibrahim AhmedDepartment of chest Ds & TB, Faculty of Medicine, Fayoum University, Fayoum, Egypt.
Hasnaa OsamaClinical Pharmacy Department, Faculty of Pharmacy, Beni-suef University, Beni-suef, Egypt.
Amira Karam KhalifaDepartment of Medical pharmacology, Kasr El-Ainy School of Medicine, Cairo University, El Manial, Cairo, 11562, Egypt.
Abdullah Ali AlshehriDepartment of Clinical Pharmacy, College of Pharmacy, Taif University, Al Hawiyah, Taif, Saudi Arabia.
Gaber El-Saber BatihaDepartment of Pharmacology and Therapeutics, Faculty of Veterinary Medicine, Damanhour University, Damanhour, AlBeheira, 22511, Egypt.
Walaa A NegmDepartment of Pharmacognosy, Faculty of Pharmacy, Tanta University, Tanta, 31527, Egypt. walaa.negm@pharm.tanta.edu.eg.ORCID http://orcid.org/0000-0003-0463-8047
Marwa KamalClinical Pharmacy Department, Faculty of Pharmacy, Fayoum University, Fayoum, 63514, Egypt.
Fayoum University · EGBeni-Suef University · EGCairo University · EGDamanhour University · EGTaif University · SATanta University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A positive response in reversibility testing is widely used to diagnose patients with airway limitations. However, despite its simple procedure, it doesn't accurately reflect the exact airway irreversibility. This study aimed to investigate the efficacy of a bronchodilation reversibility test using salbutamol and fluticasone/salmeterol combination in obese non-smoker subjects.The study included patients without a history of obstructive lung disease or bronchodilators. A sub-classification of patients based on body mass index (BMI) was carried out into normal (< 24.9 kg/m

Indexed as

Bronchodilator AgentsObesity, MorbidAdministration, InhalationAdultAlbuterolDouble-Blind MethodFemaleFluticasone-Salmeterol Drug CombinationForced Expiratory VolumeHumansMaleMiddle AgedNon-SmokersOverweightSalmeterol XinafoateAlbuterolBronchodilator AgentsFluticasone-Salmeterol Drug CombinationSalmeterol XinafoateBronchodilatorsObese, fluticasone/salmeterolReversibility testSalbutamolSpirometry

Identifiers

PMID37814253
PMCPMC10563321
OpenAlexW4387449956

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.